Candriam SCA’s NuVasive, Inc. NUVA Stock Holding History

Candriam SCA’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-29,000	Closed	-$1.4M	–	684
2016 Q1	$1.4M	Buy	29,000 +6,000	+26%	+$272K	0.04%	376
2015 Q4	$1.25M	Buy	23,000 +10,000	+77%	+$510K	0.03%	365
2015 Q3	$627K	Sell	13,000 -8,000	-38%	-$413K	0.02%	495
2015 Q2	$995K	Sell	21,000 -32,000	-60%	-$1.5M	0.02%	448
2015 Q1	$2.44M	Buy	53,000 +26,000	+96%	+$1.21M	0.05%	362
2014 Q4	$1.27M	Buy	+27,000	New	+$1.13M	0.03%	415

Other funds holding NUVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Candriam SCA's NUVA Position: Q2 2016 in Review

Candriam SCA sold out of NuVasive, Inc. (NUVA) in Q2 2016, closing a stake of 29,000 shares — an estimated $1.4M sold.

Candriam SCA first reported a position in NUVA in Q4 2014 and held it in 6 quarters. The position peaked at $2.44M in Q1 2015. 257 funds tracked by Wall St. Rank hold NUVA as of Q2 2016.

Candriam SCA reported no remaining NuVasive, Inc. position as of Q2 2016 after selling out during the quarter.
Candriam SCA sold 29,000 NuVasive, Inc. shares in Q2 2016, an estimated $1.4M.
Candriam SCA first reported a position in NuVasive, Inc. in Q4 2014 and held it in 6 quarters.
Candriam SCA's NuVasive, Inc. position peaked at $2.44M in Q1 2015.
257 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2016.

Based on Candriam SCA's 13F filing for Q2 2016, filed 26 Jul 2016.